Business Context and Reporting Period
This Form 8-K is a current report filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc., as noted in the request metadata) on November 5, 2009. The filing serves to announce the company's financial results for the fiscal quarter ended September 30, 2009 under Item 2.02.
Key Financial Metrics
The filing text itself does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. These figures are referenced as being contained within the press release furnished as Exhibit 99.1, which is not included in the provided source text.
Material Changes
No material changes or comparative financial data versus prior periods are detailed in the body of this Form 8-K. The document solely acts as a notification that results have been issued.
Guidance, Outlook, and Risks
The filing does not provide management commentary, forward-looking guidance, risk factors, or details on contingencies. It strictly references the issuance of a press release for the quarter's results.
Investor Verification Checklist
- Verify the actual financial figures (revenue, net income, cash position) by reviewing Exhibit 99.1 (the press release dated November 5, 2009), as they are absent from this summary document.
- Confirm the registrant name is Oculus Innovative Sciences, Inc., noting the discrepancy with the "Sonoma Pharmaceuticals" name in the request metadata.
- Check for any subsequent filings or updates regarding the fiscal quarter ended September 30, 2009, if the press release is unavailable.